People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dna Seq 2, Inc. | — | Pharmaceuticals | Seed | $1.2M | $6.3M | 2024 |
Stuart E. Siegel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stuart E. Siegel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas M. Wheeler | 1 | 1 |
| Benjamin M. Anderson | 1 | 1 |
| Janusz Maria Sowadski | 1 | 1 |
| Eric Maria Ladizinsky | 1 | 1 |
| Andrew Nappin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.